ClinicalTrials.gg
Sign In

Meniere Disease clinical trials

The registry lists 74 studies for Meniere Disease across more than 10 countries. 12 are recruiting or about to start. 58 of them are mainly about Meniere Disease (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-16.

Get an email when these change. Save the Meniere Disease studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
38
Recruiting
11
Terminated
9
Status unknown
8
Active, not recruiting
4
Withdrawn
2

Phase

Phase 2
16
Phase 3
13
Phase 4
9
Phase 1
7
Early Phase 1
1

Where

United States
29
United Kingdom
7
China
5
France
5
Germany
3
Japan
3

Who runs them

Otonomy, Inc. (9) · Sound Pharmaceuticals, Incorporated (5) · University Hospital, Grenoble (4) · Beijing Tongren Hospital (4) · Osaka University (3) · Otolith Labs (3) · Norfolk and Norwich University Hospitals NHS Foundation Trust (3) · Seoul National University Hospital (2)

What is being tested here

Drugs under test in Meniere Disease studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Methylprednisolone122
Interleukin 1 Receptor Antagonist Protein102
Nortriptyline101
Topiramate101
Dexamethasone058
Sustained-Exposure Dexamethasone Formulation OTO-104058
Ebselen024
Lamotrigine002
Montelukast001
Tetracaine001

Drug classes tested here Corticosteroids 1 open

Coming up

2phase 3 studies under way
4studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4, phase 3 first

Who these studies take

Of the 11 Meniere Disease studies recruiting now, 5 (45%) set no upper age limit and 2 (18%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 4 (36%) take healthy volunteers.

Recruiting studies that take each age, of 11
AgeWomenMen
100 (0%)0 (0%)
189 (82%)9 (82%)
3011 (100%)11 (100%)
4011 (100%)11 (100%)
5011 (100%)11 (100%)
6511 (100%)11 (100%)
7510 (91%)10 (91%)
857 (64%)7 (64%)

Across all 74 studies, recruiting or not: 34% stop at 75 or younger and 11% at 65; 5% take children; 0% are for women only and 0% for men only; 14% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Meniere Disease studies take

Of 14 interventional studies with no phase under Meniere Disease, half reached primary completion within 16 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase16 mo10–42 · 14 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 74. Browse all 74 → or search them.